NCT07412418Not yet recruiting
Screening for Pulmonary Embolism Using Single-channel Electrocardiogram
Screening for Pulmonary Embolism Using Single-channel Electrocardiogram Data Using Machine Learning Models
Source: ClinicalTrials.gov · Last updated 1 May 2026
Brief summary (registry, in English)
It is a prospective, controlled, single-center, observational, non-randomized study. The study is planned to include at least 500 patients 18 years old and older (300 patients in the training sample and 200 patients in the test sample. The study will include all patients requiring exclusion of the diagnosis of acute pulmonary embolism. Patients will be examined according to clinical guidelines to confirm the diagnosis of pulmonary embolism (laboratory, clinical and instrumental). During the course of the study, the authors of the work do not interfere with the scope of the examination, which is caried out on patients in accordance with clinical guidelines. All patients included in the study will undergo electrocardiogramm (ECG) in standart lead I for 1 minute, followed by spectral analysis of the obtained data, which will be stored at the Remote monitoring center of Sechenov University without being linked to the personal data of patients. A spectral analysis of the electrocardiogram will be performed using a continuous wavelet transformation. The result of this study will be the identification of ECG parameters that will correlate with pulmonary embolism.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 9 Feb 2026
- Start date
- May 2026
- Primary completion date
- Mar 2028
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Diseases
- COPD
- NCT number
- NCT07412418
What you commit to
- Study type: Observational
- Planned participants: 500
- From May 2026 to the primary completion date, Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Poor ECG quality, preventing the necessary analysis of a single-channel ECG;
- Incomplete examination, preventing a reliable determination of the presence or absence of pulmonary embolism;
- Refusal to further participate in the study.
Who the study is looking for
- A clinical condition requiring exclusion of acute pulmonary embolism;
- The presence of written informed consent of the patient to participate in the study;
- Age from 18 years old and older
- Non-inclusion criteria:
- Refusal to undergo examination or the inability to reliably verify or exclude the diagnosis of pulmonary embolism;
- Treatment, in particular anticoagulant therapy, before recording a single-lead ECG;
- Conditions in which recording an ECG in lead I is not possible (congenital anomalies of the upper limbs, traumatic amputation of the upper limbs, tremor, etc.);
- Refusal to sign written informed consent to participate in the study.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Clinical Hospital №1, Sechenov University Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.